TL;DR
Recent literature concerning lncRNA CCAT2’s role in the development and progression of different GI cancers, its interaction with cancer-related molecular mechanisms, and its potential as a diagnostic and prognostic biomarker in GI patients are reviewed.
AI-generated by Semantic Scholar
Authors
Ahmad Ghorbani Vanan, Farid Ghorbaninezhad, Golnaz Nikeghbali, Fateme Mohamadi, Ariyan Ayati, Reza Ghanbari Mastani, Zahra Shahhoseini, Pooya Eini, Ronak Ahmadi, Safa Tahmasebi, Elham Safarzadeh
